close
MENU
Tech & Innovation
4 mins to read

Bowel device company to raise further $2m-$3m in wholesale offer

The Insides Company says the market will still back a 'good proposition'.

The Insides Company's novel chyme reinfusion device.

The Insides Company, which is commercialising a device that improves recovery from potentially life-threatening bowel conditions, is planning to raise between $2 million and $3 million in an offer to wholesale investors.

The pending offer on the Snowball Effect platform is on the same terms as the

Want to read more? It's easy.

Choose your best value subscription option

Student

Exclusive offer for uni students studying at a New Zealand university (valued at $499).
Individual
Group membership
NBR Marketplace

Yearly Premium Online Subscription

NZ$499.00 / yearly

Monthly Premium Online Subscription

NZ$44.95 / monthly

Smartphone Only Subscription

NZ$24.95 / monthly

Premium Group Membership 10 Users

NZ$350+GST / monthly

$35 per user - Pay by monthly credit card debit

Premium Group Membership 20 Users

NZ$600+GST / monthly

$30 per user - Pay by monthly credit card debit

Premium Group Membership 50 Users

NZ$1250+GST / monthly

$25 per user - Pay by monthly credit card debit

Premium Group Membership 100 Users

NZ$1875+GST / monthly

$18.75 per user - Pay by monthly credit card debit

Yearly Premium Online Subscription + NBR Marketplace

NZ$499.00 / yearly

Already have an account? Login
Fiona Rotherham Thu, 08 Dec 2022
Contact the Writer: fiona@nbr.co.nz
News tip? Question? Typo? Let us know: editor@nbr.co.nz
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Bowel device company to raise further $2m-$3m in wholesale offer
Tech & Innovation,
96961
true